John M. Essigmann

15.4k citations

167 papers · 12.3k indexed · 2 hit papers · h-index 59

Impact in

Cancer Research top 0.2%
- Carcinogens and Genotoxicity Assessment
Molecular Biology top 0.5%
- DNA Repair Mechanisms
- DNA and Nucleic Acid Chemistry
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- CRISPR and Genetic Engineering

Papers in

Cancer Research 51
- Carcinogens and Genotoxicity Assessment 45
Molecular Biology 136
- DNA Repair Mechanisms 89
- DNA and Nucleic Acid Chemistry 60
- Epigenetics and DNA Methylation 18
- Advanced biosensing and bioanalysis techniques 15
- RNA modifications and cancer 11

Co-authors: James C. Delaney Maria Kartalou Gerald N. Wogan William L. Neeley Robert G. Croy Bogdan I. Fedeles David Wang Vipender Singh
Journals: Proceedings of the National Academy of Sciences (29 papers)Biochemistry (19 papers)Chemical Research in Toxicology (15 papers)Journal of Biological Chemistry (11 papers)Journal of the American Chemical Society (8 papers)
Partner nations: United States Thailand United Kingdom

In The Last Decade

John M. Essigmann

165 papers receiving 11.9k citations

Hit Papers

align trajectories log scale

Mechanisms of resistance to cisplatin 2001 · 757 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Mutation research. Fundamental and molecular mechanisms of mutagenesis
1977 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by John M. Essigmann

Since Specialization

Citations

This map shows the geographic impact of John M. Essigmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Essigmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Essigmann more than expected).

Fields of papers citing papers by John M. Essigmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Essigmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Essigmann. The network helps show where John M. Essigmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John M. Essigmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John M. Essigmann Line = papers co-authored together John M. Essigmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	5-Chloro-2′-deoxycytidine Induces a Distinctive High-Resolution Mutational Spectrum of Transition Mutations In Vivo Chemical Research in Toxicology ·Umirov Abdusalom Turaevich, Zhiyu Yang, Y.Y. Yeow, Nina Gubina, Mathuros Ruchirawat, Robert G. Croy, Bogdan I. Fedeles, John M. Essigmann	2024	3
2	Molecular origins of mutational spectra produced by the environmental carcinogen N-nitrosodimethylamine and SN1 chemotherapeutic agents NAR Cancer ·Amanda L. Armijo, L. E. HARRIS, Bogdan I. Fedeles, Jeison Henao Pérez, Jennifer E. Kay, Joshua J. Corrigan, Umirov Abdusalom Turaevich, Ryoei Harasawa, Leona D. Samson, Sebastian E. Carrasco, Bevin P. Engelward, James G. Fox, Robert G. Croy, John M. Essigmann	2023	9
3	Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B1 as a case study DNA repair ·Bogdan I. Fedeles, John M. Essigmann	2018	32
4	NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice Proceedings of the National Academy of Sciences ·Vladimir L. Vartanian, Irina G. Minko, Ryoei Harasawa, Patricia A. Egner, Timothy D. Phillips, Lauriel F. Earley, Rosemary Makar, Jennifer Eng, Ana Keyla Carmo Lopes, Liang Li, Michael P. Stone, Michael Lasarev, John D. Groopman, Robert G. Croy, John M. Essigmann, Amanda K. McCullough, R. Stephen Lloyd	2017	50
5	Early detection of the aflatoxin B₁ mutational fingerprint: A diagnostic tool for liver cancer Molecular & Cellular Oncology ·Bogdan I. Fedeles, Ryoei Harasawa, Robert G. Croy, Gerald N. Wogan, John M. Essigmann	2017	12
6	Early Detection of the Aflatoxin B₁ Mutational Fingerprint: A Diagnostic Tool for Liver Cancer DSpace@MIT (Massachusetts Institute of Technology) ·Bogdan I. Fedeles, Ryoei Harasawa, Robert G. Croy, Gerald N. Wogan, John M. Essigmann	2017	5
7	The AlkB Family of Fe(II)/α-Ketoglutarate-dependent Dioxygenases: Repairing Nucleic Acid Alkylation Damage and Beyond Journal of Biological Chemistry ·Bogdan I. Fedeles, Vipender Singh, James C. Delaney, Deyu Li, John M. Essigmann	2015	322
8	Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1 Toxicology and Applied Pharmacology ·M Schwenk, Bárbara Villani Buranelli, Panida Navasumrit, Robert G. Croy, Gerald N. Wogan, John D. Groopman, Mathuros Ruchirawat, John M. Essigmann	2014	21
9	Alleviation of 1, N ⁶ -ethanoadenine genotoxicity by the Escherichia coli adaptive response protein AlkB Proceedings of the National Academy of Sciences ·Lauren E. Frick, James C. Delaney, Cintyu Wong, Catherine L. Drennan, John M. Essigmann	2007	53
10	AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo Nature Structural & Molecular Biology ·James C. Delaney, Lisa Smeester, Cintyu Wong, Lauren E. Frick, Koli Taghizadeh, John S. Wishnok, Catherine L. Drennan, Leona D. Samson, John M. Essigmann	2005	162
11	In Vivo Bypass Efficiencies and Mutational Signatures of the Guanine Oxidation Products 2-Aminoimidazolone and 5-Guanidino-4-nitroimidazole Journal of Biological Chemistry ·William L. Neeley, James C. Delaney, Paul T. Henderson, John M. Essigmann	2004	56
12	The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis Carcinogenesis ·王卫权, A.S. Popova, Elisabeth A. Bailey, John M. Essigmann	2001	241
13	Context-dependent mutagenesis by DNA lesions Chemistry & Biology ·James C. Delaney, John M. Essigmann	1999	48
14	Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions Mutation research. Fundamental and molecular mechanisms of mutagenesis ·David Wang, Nicholas H. Ramazon, John M. Essigmann	1998	400
15	The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin Chemistry & Biology ·Jill A. Mello, Samir Acharya, Richard Fishel, John M. Essigmann	1996	163
16	An ultraviolet light-damaged DNA recognition protein absent in xeroderma pigmentosum group E cells binds selectively to pyrimidine (6–4) pyrimidone photoproducts Nucleic Acids Research ·Daniel K. Treiber, Koraljka Sansović, John M. Essigmann	1992	60
17	Comparative efficiency of forming m4T.cntdot.G versus m4T.cntdot.A base pairs at a unique site by use of Escherichia coli DNA polymerase I (Klenow fragment) and Drosophila melanogaster polymerase .alpha.-primase complex Biochemistry ·Manjit Dosanjh, John M. Essigmann, Myron F. Goodman, B. Singer	1990	33
18	Site-specifically alkylated oligodeoxynucleotides: Probes for mutagenesis, DNA repair and the structural effects of DNA damage Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Ashis K. Basu, John M. Essigmann	1990	44
19	Possible role for thymine glycol in the selective inhibition of DNA synthesis on oxidized DNA templates. PubMed ·Dennis R. Hunt, John M. Essigmann	1985	89
20	Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats. PubMed ·Richard A. O. Bennett, John M. Essigmann, Gerald N. Wogan	1981	85

About John M. Essigmann

John M. Essigmann is a scholar working on Cancer Research, Molecular Biology, Chemical Health and Safety, Plant Science and Virology, having authored 167 papers that have together received 12.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (89 papers), DNA and Nucleic Acid Chemistry (60 papers), Carcinogens and Genotoxicity Assessment (45 papers), Mycotoxins in Agriculture and Food (19 papers), Epigenetics and DNA Methylation (18 papers), Advanced biosensing and bioanalysis techniques (15 papers), Metal complexes synthesis and properties (12 papers) and RNA modifications and cancer (11 papers). The work is most often cited by research in Cancer Research (3.0k citations), Molecular Biology (9.3k citations), Oncology (2.0k citations), Toxicology (154 citations) and Plant Science (1.6k citations). John M. Essigmann has collaborated with scholars based in United States, Thailand and United Kingdom. Frequent co-authors include James C. Delaney, Maria Kartalou, Gerald N. Wogan, William L. Neeley, Robert G. Croy, Bogdan I. Fedeles, David Wang, Vipender Singh, Deyu Li and Paul T. Henderson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemistry, Chemical Research in Toxicology, Journal of Biological Chemistry and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact